Programming - Hypertension Scientific Sessions

September 5–8, 2024
Hilton Chicago | Chicago, Illinois

Schedule at a Glance

All times are Central Standard Time (CST) (UTC - 6) Wednesday, Sept. 4

Time
7:00 p.m. to 9:00 p.m.	Hypertension and KCVD Member Welcome Reception - NEW THIS YEAR! Tickets Required

Thursday, Sept. 5

Time	Recent Advances/Basic/TAC Sessions	Clinical/Primary
7:30 a.m. to 9:00 a.m.	Session 1 - Opening Remarks and Keynote Lecture Chairs: R. Ariel Gomez, MD, FAHA and Jane Reckelhoff, PhD, FAHA Presidential Remarks Keith Churchwell, MD, FAHA Welcome Jane Reckelhoff, PhD, FAHA Opening Keynote Lecture Chairs: Sylvia Medrano, PhD, and Justin Grobe, PhD, FAHA Insights into Acute Kidney Injury and Transition to Chronic Kidney Disease Revealed by Multiomic and Spatial Technologies Benjamin D. Humphreys, MD, PhD
9:00 a.m. to 10:00 a.m.	Session 2 - Keynote Lecture Chairs: Cameron G. McCarthy, PhD, FAHA and TBD Immune Mechanisms of Hypertension David Harrison, MD, PhD
10:00 a.m. to 10:30 a.m.	Break
10:30 a.m. to 12:00 p.m.	Session 3 - Recent Advances Session (plenary) - New Drugs in the Treatment of Hypertension Chairs: Licy L. Yanes Cardozo, MD and Brandy Wynne, PhD, FAHA Mechanisms of Endothelin, ETA and ETB Receptors in Hypertension David M. Pollock, PhD Endothelin Antagonists for Hypertension: Has Their Time Finally Arrived? Ernesto L. Schiffrin, CM, MD, PhD, FRSC, FRCPC, FACP, FAHA The Potential Role of Aldosterone Synthase Inhibition to More Effectively Treat Hypertension Luke Laffin, MD
12:00 p.m. to 1:00 p.m.	Session 4 - Meet the Keynote Speakers Benjamin D. Humphreys, MD, PhD David G. Harrison, MD, FAHA Alexander Staruschenko, PhD, FAHA Early Career Networking Event
1:00 p.m. to 1:30 p.m.	Lunch on your own/Break
1:30 p.m. to 3:00 p.m.	Session 5 - Recent Advances Session (plenary) The Evolving Story of APOL1-Mediated Kidney Disease: Transforming Understanding of Hypertension and Kidney Disease in those of African Ancestry Chairs: Thu Le, MD, FAHA and Mildred A. Pointer, PhD, FAHA Review of the Evolution of the Mechanistic Understanding of APOL1 High Risk Variants on Kidney Disease and Hypertension John R. Sedor, MD Understanding the Impact of APOL-1 Pore-Forming Function: From Epidemiology to In Vitro Studies Adriana M. Hung, MD, MPH Treatment for APOL-1 Related Proteinuric Kidney Disease – Are We There Yet? Ogo Egbuna, MD
3:00 p.m. to 3:30 p.m.	Break
3:30 p.m. to 5:30 p.m.	Session 6 - Oral Abstract Sessions Concurrent A Concurrent B	Session 6C - Clinical Practice/Clinical Science 3:30pm to 4:30pm - 6C1: Primary Aldosteronism - What you need to know Moderators: Adina Turcu, MD, MS and Matt Luther Who and when to screen? Vivek Bhalla, MD, FASN, FAHA What testing should you perform? Jenifer M. Brown, MD How to titrate treatment? Gregory L. Hundemer, MD MPH 4:30 – 5:30 - 6C2: Debate: Management of Resistant Hypertension- Drugs, Devices, or Lifestyle Moderators: Paul E Drawz and Anna Katherine Krawisz, MD Just give me a med! Jennifer L. Cluett, MD, FAHA Just fix it with a catheter! Debbie Cohen, MD Lifestyle is the way to go! TBD
5:30 p.m. to 7:00 p.m.	POSTER SESSION 1: TAC Poster session/competition and reception

Friday, Sept. 6

Time	Recent Advances/Basic	Clinical/Primary
7:15 a.m. to 7:45 a.m.	Industry Learning Studio Astra Zeneca
7:00 a.m. to 7:45 a.m.	Session 7 - American Heart Association Research: Grant Funding and Other Opportunities Glenn Dillon, PhD
8:00 a.m. to 9:00 a.m.	Session 8 - Recent Advances Session (plenary) : Mechanisms of Neurovascular Coupling and Hypertension Chairs: Monica Santisteban, PhD and Yumei Feng-Earley, MD, PhD, FAHA Advanced Neuroimaging to Predict the Impact of Hypertension on Brain Health Guiseppe Lembo, MD. PhD Hypertension and Brain Health: From Vascular Cognitive Impairment to Alzheimer’s Disease Costantino Iadecola, MD
9:00 a.m. to 10:30 a.m.	POSTER SESSION 2 (with Breakfast reception)
10:30: a.m. to 12:00 p.m.	Session 9 - Recent Advances Session (plenary): Hypertension without Borders Chairs: Anastasia Mihailidou, PhD and Marianne Bertagnoli, PhD Improving Hypertension Control in Populations With Health Disparities Jiang He, MD, PhD Closing the Gap: Practical Strategies for Global BP Control Equity Tazeen Hasan Jafar, MD, MPH Current Situation of Hypertension Incidence and Treatment in Japan Shigeru Shibata, MD, PhD, FASN, FAHA
12:00 p.m. to 1:30 p.m.	Lunch on your own/Exhibits
12:00 p.m. to 12:30 p.m.	Industry Sponsored Learning Studio - Medtronic
12:00 p.m. to 1:30 p.m.	Session 10: Trainee Advocacy Committee CHAMP Lunch
1:30 p.m. to 3:00 p.m.	Session 11 - Recent Advances Session (plenary): Dietary Approaches to Hypertension Chairs: Bina Joe, PhD, FAHA, FAPS, ISHF and Daniela Carnevale, PhD, FAHA Dissecting the Good and Bad Effects of Dietary Potassium on Blood Pressure Robert Fenton, PhD Leveraging the Microbiota as Medicine for Hypertension David Durgan, PhD Dietary Approaches to Stop Hypertension (DASH): 1994-2024 Laura P. Svetkey, MD MHS
3:00 p.m. to 3:30 p.m.	Break
3:30 p.m. to 5:00 p.m.	Session 12 - Annual Hypertension Awards Session Moderators: Cam McCarthy, PhD, FAHA and Monica M. Santisteban, PhD The Stephanie Watts Award finalist presentations British-Irish Hypertension Award Ryan McNally, MPharm, PhD Council on Hypertension Research Award cosponsored by Hypertension Australia Effects of sodium ascorbate versus ascorbic acid in improving vasopressor response in sepsis Connie Ow, PhD New Investigator Award for Japanese Fellows Harry Goldblatt Award for New Investigators	Session 12C - Clinical Practice/Clinical Science (CPCS) 3:30 - 4:30: 12C1 - What is CKM and PREVENT? Moderators: Kristi Reynolds, PhD, MPH and Eugene Yang, MD, MS Overview of AHA CKM Chiadi Ndumele, MD, PhD, FAHA PREVENT Risk Calculator Sadiya Khan, MD, MSc Pros and Cons of PREVENT Clyde W Yancy, MD, MSc 4:30 – 5:30: 12C2- Debate: Management of Obesity Associated Hypertension- Drugs, Surgeries, or Lifestyle Moderators: John D. Bisognano, MD PhD and Meena Madhur, MD, PhD Just give me the shot! Tamar Polonsky, MD Just give me the surgery! Alfonso Torquati MD, MSCI, FACS Just focus on your diet! TBD
5:00 p.m. to 6:00 p.m.	Oral Abstract Sessions Concurrent A Concurrent B
6:00 p.m. to 7:00 p.m.	Session 13 The Arthur C. Corcoran Memorial Lecture The Lewis K. Dahl Memorial Lecture
7:30 p.m. to 10:30 p.m.	Trainee Advocacy Mixer

Saturday, Sept. 7

Time	Recent Advances/Basic/TAC	Clinical/Primary
7:30 a.m. to 9:30 a.m.	Session 14 7:30 to 8:00 - The Donald Seldin lecture 8:00 to 9:30 - Oral Abstract Sessions Concurrent A Concurrent B	Session 14C - Clinical Practice/Clinical Science (CPCS) 7:30 to 8:30 - 14C1: Hypertension Cases with the Experts- How would you manage these patients? Moderators: Jan Basile, MD and Raven Voora, MD Case 1: Patient cannot tolerate any medications Presented by Johnathan Ravid, MD Case 2: Wide Pulse Pressure, SBP remains high, DBP low Presented by Mason Yoder, MD Case 3: Intermittent BP elevations / "spikes" TBD Case 4: Severe autonomic dysfunction Presented by Pedro Ortiz, MD 8:30 to 9:30 - 14C2: Clinical Trials- How do we make them better! Moderators: Sydney Hartsell, MD, MPH and Erica S Spatz. MD For which patients do we need more evidence? William C. Cushman, MD, FAHA Do decentralized trials in hypertension make sense? Lama Ghazi, MD PhD How should we measure BP in clinical trials? Joseph Ebinger, MD
9:30 a.m. to 10:00 a.m.	Break
10:00 a.m. to 12:00 p.m.	Session 15 10:00 to 10:30 - Harriet Dustan Award 10:30 to 12:00 - Oral Abstract Sessions Concurrent A Concurrent B	Session 15C - Primary Care 10:00 to 11:00 - 15C1 - Picking the Right Drugs for the Right Patient Moderators: C. Adair Blyler, PharmD and TBD Classy treatment of hypertension: Everything you wanted to know about hypertension drug classes and side effects Adam Bress, PharmD Tailoring therapy for distinct populations Karen A. Griffin, MD, FAHA Combination therapy Brent M. Egan, MD 11:00 to 12:00 - 15C2 - Partnering with Patients to Initiate and Adhere to Treatment Moderators: Bunmi Ogungbe, PhD, MPH, RN Patient communication TBD Social determinants of health TBD Cultural and structural competency Stephanie Fitzpatrick, PhD, FSBM
12:00 p.m. to 12:30 p.m.	Industry Sponsored Learning Studio - Recor
12:30 p.m. to 1:30 p.m.	Session 16 - Grantsmanship for Early Career Investigators Sponsored by the Trainee Advocacy Committee Chairs: Cameron McCarthy, PhD, FAHA and Carmen De Miguel, PhD, MS, FAHA NIH Grant Review Process Youngsuk Oh, PhD Panelists: Richard Wainford, PhD, FAHA Michelle Gumz, PhD, FAHA Camilla Ferreira Wenceslau, PhD, FAHA Alexander Staruschenko, PhD, FAHA Paul Welling, MD, FAHA
12:30 p.m. to 1:30 p.m.	Session 17 - Hypertension Meet the Editors Networking Event
1:30 p.m. to 3:00 p.m.	Session 18 - TAC Oral Abstract Sessions Concurrent A Concurrent B	Session 18C - Hypertension Case Study Session: Hickam’s Dictum in Hypertension Chairs Rhian Touyz and David Harrison Hickam’s Dictum in Hypertension Gregory L. Hundemer, MD, MPH Swapnil Hiremath, MD, MPH Contemporary Use of an Old Drug: Minoxidil for Resistant/Refractory Hypertension Michael Bursztyn, MD Iddo Z. Ben-Dov, MD, PhD
3:00 p.m to 3:30 p.m.	Break
3:30 p.m. to 5:30 p.m.	Session 19 3:30 to 4:00 - KCVD Mid-Career Achievement Award COH Mid-Career Award for Research Excellence 4:00 to 5:30 - Oral Abstract Sessions Concurrent A Concurrent B	Session 19C - Primary Care 3:30 to 4:30 - 19C1: Blood Pressure Measurement Moderators: Steven A Yarows, MD and Hilary K. Wall, MPH Standardization: Getting the most out of the office measurement TBD Incorporating patient-measured blood pressure into clinical care: best practices/use cases Karen Margolis, MD, MPH Numbers you can use: devices and approaches TBD 4:30 to 5:30 - 19C2: Off the Cuff: "Podcast" Interview with the Experts Podcaster: Swapnil Hiremath, MD, MPH Hypertension Experts Shawna D. Nesbitt MD, MS Michael Rakotz, MD, FAHA, FAAFP
5:45 p.m. to 6:45 p.m.	Session 20 - Excellence Award for Hypertension Research Lecture
8:00 p.m. to 10:30 p.m.	Hypertension Awards Banquet

Sunday, Sept. 8

Time	Recent Advances/Basic/TAC	Clinical/Primary
7:30 a.m. to 9:00 a.m.	Session 21 - Recent Advances (plenary) - Hypertension and Women's Health Chairs: Jessica Faulkner, PhD, FAHA and Amy C. Arnold, PhD, FAHA Sex Differences in Resilience to Hypertension Heddwen Brooks, PhD New Concepts in Immune Mechanisms of Preeclampsia Babbette LaMarca, PhD Renal Hemodynamics in Pregnancy Phyllis August, MD, MPH
9:00 a.m. to 9:30 a.m.	Break
9:30 a.m. to 11:0 a.m.	Session 22 Oral Abstract Sessions Concurrent A Concurrent B	Session 22C Primary Care Clinical Lectures 9:30 - 10:00 Moderator: Joyce P. Samuel, MD Hypertension Management in Young People Joshua Samuels, MD, MPH 10:00 - 10:30 Moderator: Jordana Cohen Secondary Hypertension Richard J. Auchus, MD, PhD 10:30 - 11:00 Moderator: Jesus Melgarejo, MD, PhD Hypertension Management in Older Adults TBD
11:00 a. m. to 11:30 a.m.	Session 23 - Final Keynote KCVD Past Chair Lecture Kidney Metabolism and its Role in Hypertension Alexander Staruschenko, PhD, FAHA
11:30 a.m.	Meeting Adjourns

About This Meeting

Hypertension 2024 Scientific Sessions, focusing on recent advances in basic and clinical research on hypertension, is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.

This year's programming also includes:

Recent Advances sessions
Clinical Science/Clinical Practice Track
Primary Care Track
Oral abstract sessions highlighting early career oral abstract presentations
Networking sessions
Trainee Advocacy Committee Poster session and competition
Award Lecture sessions

2024 Learning Objectives

Discuss recent advances and emerging experimental models in hypertension.
Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive disorders.
Describe new therapeutic options for patients with hypertension.
Describe best practices in the management of and scientific research in hypertensive disorders.
Describe innovative approaches to conducting basic and/or clinical research.